Yield10 Bioscience, Inc.

YTEN · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$3,238-$2,472-$3,266-$3,726
Dep. & Amort.$60$66$73$72
Deferred Tax$0$0$383$0
Stock-Based Comp.$360$412$292$407
Change in WC$2,118$967$966$554
Other Non-Cash$126$124-$159$82
Operating Cash Flow-$574-$903-$1,711-$2,611
Investing Activities
PP&E Inv.$0$0-$20$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$20$1
Financing Activities
Debt Repay.$0$0$0-$33
Stock Issued$7$0-$5,842$5,842
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$326$1,211$5,842-$2,717
Financing Cash Flow-$326$1,211$0$3,092
Forex Effect$0$4-$18-$1
Net Chg. in Cash-$899$312-$1,749$481
Supplemental Information
Beg. Cash$1,644$1,332$2,817$2,600
End Cash$745$1,644$1,068$3,081
Free Cash Flow-$574-$903-$1,731-$2,610
Yield10 Bioscience, Inc. (YTEN) Financial Statements & Key Stats | AlphaPilot